239

46 - settembre 2019 - Minuti other complementary treatments for episodic migraine pre- vention in adults: report of the Quality Standards Subcom- mittee of the American Academy of Neurology and the Ame- rican Headache Society. Neurology. 2012;7 8(17):1 346-1353. 31. von Luckner A, Riederer F. Magnesium in migraine pro- phylaxis—is there an evidence-based rationale? A systematic review. Headache. 2018; 58(2):1 99-209. 32. Campbell JK, Penzien DB, Wall EM; US Headache Con- sortium; American Academy of Family Physicians; American Academy of Neurology; American Headache Society; Ame- rican College of Emergency Physicians; American College of Physicians-American Society of Internal Medicine; Ame- rican Osteopathic Association; National Headache Founda- tion. Evidence-based guidelines for migraine headache: be- havioral and physical treatments. http:// tools.aan.com/pro- fessionals/practice/pdfs/gl0089.pdf. Accessed August 3, 2018. 33. Linde K, Allais G, Brinkhaus B, et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev. 2016;( 6):C D001218. 34. Maasumi K, Tepper SJ, Kriegler JS. Menstrual migraine and treatment options: review. Headache. 2017;5 7(2):1 94-208. 35. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S; American Academy of Neurology Quality Stan- dards Subcommittee; Practice Committee of the Child Neu- rology Society. Practice parameter: pharmacological treat- ment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Stan- dards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;6 3(12):2 215-2224. 36. Martin SR, Foley MR. Approach to the pregnant patient with headache. Clin Obstet Gynecol. 2005;4 8(1):2 -11. 37. Silberstein SD. Headaches in pregnancy. J Headache Pain. 2005;6 (4): 172-174. eTabella A. Altri farmaci (con evidenze meno chiare) per la prevenzione dell’emicrania episodica Possibilmente efÿcaci Candesartan Carbamazepina Lisinopril Nebivololo Nicardipina Dati non-univoci o insufÿcienti per supportare il trattamento Bisoprololo Fluoxetina Gabapentina Nifedipina Nimodipina Pindololo Proptriptilina Verapamil Inefÿcaci Acebutololo Lamotrigina Oxcarbazepina Telmisartan Informazioni tratte da: Silbersten SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: Report on the Quality Standard Subcommittee of the American Academy of Neurology and the American He- adache Society [published corrections appear in Neurology . 2013; 80 (9): 871. Neurology . 2012; (78 (17): 1337-1345